Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Lumos Pharma, Inc (LUMO) had Receiveable Turnover of 9.77 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$2.05M |
|
$-34.03M |
|
-- |
|
$2.05M |
|
$38.66M |
|
$-36.61M |
|
$2.55M |
|
$-34.06M |
|
$-34.06M |
|
$-34.03M |
|
$-34.03M |
|
$-34.03M |
|
$-34.03M |
|
$-36.61M |
|
$-36.57M |
|
8.15M |
|
8.15M |
|
$-4.18 |
|
$-4.18 |
|
| Balance Sheet Financials | |
$40.03M |
|
-- |
|
$0.60M |
|
$40.64M |
|
$7.03M |
|
-- |
|
$6.30M |
|
$13.33M |
|
$27.30M |
|
$27.30M |
|
$27.30M |
|
8.10M |
|
| Cash Flow Statement Financials | |
$-31.09M |
|
$10.74M |
|
$-0.58M |
|
$56.01M |
|
$35.08M |
|
$-20.93M |
|
$2.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1785.18% |
|
-1785.18% |
|
-1783.03% |
|
-1660.80% |
|
-1659.39% |
|
$-31.09M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
|
Receiveable Turnover |
9.77 |
37.37 |
|
-124.64% |
|
-124.64% |
|
-83.75% |
|
-124.64% |
|
$3.37 |
|
$-3.82 |
|
$-3.82 |
|